Diabetes Mellitus ve Periodontal Hastalık Arasındaki Çift Yönlü İlişki

Yazarlar

Zeliha Muslu
https://orcid.org/0000-0002-7911-9711

Özet

Metin, Diabetes Mellitus (DM) ve periodontal hastalıklar arasındaki çift yönlü ve karmaşık ilişkiyi ele almaktadır. Biyofilm kaynaklı ve kronik inflamatuar bir hastalık olan periodontitis, günümüzde dünya genelinde en yaygın altıncı hastalık olarak kabul edilmektedir. Güncel 2017 sınıflandırma sisteminde, kötü kontrollü diyabet varlığı klinik parametrelerden bağımsız olarak hastalığın ilerleme hızını en yüksek seviye olan Derece C'ye yükselten majör bir risk faktörü olarak tanımlanmıştır. Diyabetik hastalarda gözlenen kronik hiperglisemi; bağışıklık sistemini baskılayarak enfeksiyon duyarlılığını artırmakta ve sağlıklı bireylere kıyasla periodontitis gelişim riskini yaklaşık üç kat, diş kaybı olasılığını ise anlamlı derecede yükseltmektedir. Mekanizmanın temelinde ortak proinflamatuar sitokinlerin (IL-1, IL-6, TNF-α) salınımı, subgingival mikrobiyotadaki sapmalar ve ileri glikasyon son ürünlerinin (AGE) kendi reseptörleri (RAGE) ile etkileşerek oksidatif stresi ve alveolar kemik yıkımını tetiklemesi yatmaktadır. Tersine, periodontal inflamasyon da glisemik kontrolü (HbA1c) olumsuz etkilemektedir. Bu nedenle, kronik süreçlerin yönetimi ve doku hasarının azaltılması amacıyla hekimlerin güncel literatürü takip etmesi, immünomodülatör ve AGE-RAGE sinyal blokajı gibi potansiyel tedavileri değerlendirmesi ve disiplinler arası iletişim kurması kritik önem taşımaktadır.

This text evaluates the bidirectional and complex relationship between Diabetes Mellitus (DM) and periodontal diseases. Periodontitis, a biofilm-induced chronic inflammatory disease, is recognized as the sixth most prevalent disease worldwide. In the current 2017 classification system, the presence of poorly controlled diabetes is defined as a major risk factor that elevates the disease progression rate to Grade C, independent of other clinical parameters. Chronic hyperglycemia observed in diabetic patients suppresses the immune system, thereby increasing susceptibility to infections, and elevates the risk of periodontitis development approximately threefold and significantly increases tooth loss compared to healthy individuals. The underlying mechanism involves the release of shared proinflammatory cytokines (IL-1, IL-6, TNF-α), shifts in subgingival microbiota, and the interaction of advanced glycation end products (AGEs) with their receptors (RAGE), triggering oxidative stress and alveolar bone resorption. Conversely, periodontal inflammation adversely affects glycemic control (HbA1c). Consequently, to manage these chronic processes and mitigate tissue destruction, it is critical for clinicians to remain updated on literature, evaluate potential therapies like immunomodulatory treatments or AGE-RAGE signal blockade, and maintain interdisciplinary communication.

Referanslar

Petersen,P.E. (2008) World Health Organization global policy for improvement of oral health - World Health Assembly 2007. Int. Dent. J., 58, 115–121. https://doi.org/10.1111/j.1875-595x.2008.tb00185.x http://www.ncbi.nlm.nih.gov/pubmed/18630105

Jascholt,I., Lai,O., Zillikens,D. and Kasperkiewicz,M. (2017) Periodontitis in oral pemphigus and pemphigoid: A systematic review of published studies. J. Am. Acad. Dermatol., 76, 975-978.e3. https://doi.org/10.1016/j.jaad.2016.10.028 http://www.ncbi.nlm.nih.gov/pubmed/28038889

Sharma,S., Sridhar,S., McIntosh,A., et al. (2021) Periodontal therapy and treatment of hypertension-alternative to the pharmacological approach. A systematic review and meta-analysis. Pharmacol. Res., 166, 105511. https://doi.org/10.1016/j.phrs.2021.105511 http://www.ncbi.nlm.nih.gov/pubmed/33617973

Tavares,L.T.R., Saavedra-Silva,M., López-Marcos,J.F., et ak. (2022) Blood and Salivary Inflammatory Biomarkers Profile in Patients with Chronic Kidney Disease and Periodontal Disease: A Systematic Review. Diseases, 10, 12. https://doi.org/10.3390/diseases10010012

Chen,Y. fei, Zhan,Q., Wu,C. zhou, et al. (2021) Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled Trails. Diabetes Ther., 12, 1249–1278. https://doi.org/10.1007/s13300-021-01000-6

Lecaplain,B., Badran,Z., Soueidan,A., et al. (2021) Periodontitis, erectile dysfunction, reproductive hormones, and semen quality: A systematic review. Andrology, 9, 769–780. https://doi.org/10.1111/andr.12961 http://www.ncbi.nlm.nih.gov/pubmed/33319469

Benz,K., Baulig,C., Knippschild,S., et al. (2021) Prevalence of oral and maxillofacial disorders in patients with systemic scleroderma—a systematic review. Int. J. Environ. Res. Public Health, 18, 1–16. https://doi.org/10.3390/ijerph18105238 http://www.ncbi.nlm.nih.gov/pubmed/34069099

Albandar,J.M., Susin,C. and Hughes,F.J. (2018) Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J. Clin. Periodontol., 45, S171–S189. https://doi.org/10.1111/jcpe.12947 http://www.ncbi.nlm.nih.gov/pubmed/29926486

Mathers,C.D. and Loncar,D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., 3, 2011–2030. https://doi.org/10.1371/journal.pmed.0030442 http://www.ncbi.nlm.nih.gov/pubmed/17132052

Newman,M., Takei,H., Klokkevold,P.R. and Carranza,M. (1996) Newman and Carranza’s Clinical Periodontology 13th ed. Elsevier. https://doi.org/10.1902/annals.1996.1.1.821 http://www.ncbi.nlm.nih.gov/pubmed/9118282

Lindhe,J. Clinical Periodontology and Implant Dentistry 6th ed.

Frencken,J.E., Sharma,P., Stenhouse,L., et al. (2017) Global epidemiology of dental caries and severe periodontitis – a comprehensive review. J. Clin. Periodontol., 44, S94–S105. https://doi.org/10.1111/jcpe.12677 http://www.ncbi.nlm.nih.gov/pubmed/28266116

Martínez-García,M. and Hernández-Lemus,E. (2021) Periodontal Inflammation and Systemic Diseases: An Overview. Front. Physiol., 12, 1–26. https://doi.org/10.3389/fphys.2021.709438

Beck,J.D., Papapanou,P.N., Philips,K.H. et al. (2019) Periodontal Medicine: 100 Years of Progress. J. Dent. Res., 98, 1053–1062. https://doi.org/10.1177/0022034519846113 http://www.ncbi.nlm.nih.gov/pubmed/31429666

Williams,R.C. and Offenbacher,S. (2000) Periodontal medicine: the emergence of a new branch of periodontology. Periodontol. 2000, 23, 9–12. https://doi.org/10.1034/j.1600-0757.2000.2230101.x http://www.ncbi.nlm.nih.gov/pubmed/11276770

Cavendish,R. (1999) Periodontal disease. Am. J. Nurs., 99, 36–37. https://doi.org/10.1097/00000446-199903000-00032 http://www.ncbi.nlm.nih.gov/pubmed/10091566

Armitage,G.C. (1999) Development of a classification system for periodontal diseases and conditions. Ann. Periodontol., 4, 1–6. https://doi.org/10.1902/annals.1999.4.1.1 http://www.ncbi.nlm.nih.gov/pubmed/10863370

The American Academy of Periodontology (1989) Proceedings of the World Workshop in Clinical Periodontics. Proc. World Work. Clin. Periodontics, :I/23-I/2.

Jepsen,S., Caton,J.G., Albandar,J.M., et al. (2018) Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol., 45, S219–S229. https://doi.org/10.1111/jcpe.12951 http://www.ncbi.nlm.nih.gov/pubmed/29926500

Saeedi,P., Petersohn,I., Salpea,P., et al. (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract., 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843 http://www.ncbi.nlm.nih.gov/pubmed/31518657

Baynest,H.W. (2015) Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. J. Diabetes Metab., 06. https://doi.org/10.4172/2155-6156.1000541

Ahmed,A.M. (2002) History of diabetes mellitus. Saudi Med. J., 23, 373–378. http://www.ncbi.nlm.nih.gov/pubmed/11953758

Patlak,M. (2002) New weapons to combat an ancient disease: treating diabetes. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol., 16, 1853. http://www.ncbi.nlm.nih.gov/pubmed/12468446

Linden,G.J. and Herzberg,M.C. (2013) Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J. Periodontol., 84, S20–S23. https://doi.org/10.1902/jop.2013.1340020 http://www.ncbi.nlm.nih.gov/pubmed/23631580

Vettore,M.V. and Sansone,C. (2009) Destructive Periodontal Disease : A Meta-Analysis.

Sima,C. and Glogauer,M. (2013) Diabetes mellitus and periodontal diseases. Curr. Diab. Rep., 13, 445–452. https://doi.org/10.1007/s11892-013-0367-y http://www.ncbi.nlm.nih.gov/pubmed/23430581

Weijdijk,L.P.M., Ziukaite,L., Van der Weijden,G.A., et al. (2022) The risk of tooth loss in patients with diabetes: A systematic review and meta-analysis. Int. J. Dent. Hyg., 20, 145–166. https://doi.org/10.1111/idh.12512 http://www.ncbi.nlm.nih.gov/pubmed/33973353

Zaccardi,F., Webb,D.R., Yates,T. and Davies,M.J. (2016) Pathophysiology of type 1 and type 2 diabetes mellitus: A 90-year perspective. Postgrad. Med. J., 92, 63–69. https://doi.org/10.1136/postgradmedj-2015-133281 http://www.ncbi.nlm.nih.gov/pubmed/26621825

Taylor,J.J., Preshaw,P.M. and Lalla,E. (2013) A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J. Clin. Periodontol., 40. https://doi.org/10.1111/jcpe.12059 http://www.ncbi.nlm.nih.gov/pubmed/23627323

Zhou,M., Rong,R., Munro,D., et al. (2013) Investigation of the Effect of Type 2 Diabetes Mellitus on Subgingival Plaque Microbiota by High-Throughput 16S rDNA Pyrosequencing. PLoS One, 8. https://doi.org/10.1371/journal.pone.0061516 http://www.ncbi.nlm.nih.gov/pubmed/23613868

Casarin,R.C.V., Barbagallo,A., Meulman,T., et al. (2013) Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J. Periodontal Res., 48, 30–36. https://doi.org/10.1111/j.1600-0765.2012.01498.x http://www.ncbi.nlm.nih.gov/pubmed/22762355

Merchant,A.T., Shrestha,D., Chaisson,C., et al. (2014) Association between serum antibodies to oral microorganisms and hyperglycemia in adults. J. Dent. Res., 93, 752–759. https://doi.org/10.1177/0022034514538451 http://www.ncbi.nlm.nih.gov/pubmed/24943202

Sakalauskiene,J., Kubilius,R., Gleiznys,A., et al. (2014) Relationship of clinical and microbiological variables in patients with type 1 diabetes mellitus and periodontitis. Med. Sci. Monit., 20, 1871–1877. https://doi.org/10.12659/MSM.890879 http://www.ncbi.nlm.nih.gov/pubmed/25294115

Aemaimanan,P., Amimanan,P. and Taweechaisupapong,S. (2013) Quantification of key periodontal pathogens in insulin-dependent type 2 diabetic and non-diabetic patients with generalized chronic periodontitis. Anaerobe, 22, 64–68. https://doi.org/10.1016/j.anaerobe.2013.06.010 http://www.ncbi.nlm.nih.gov/pubmed/23827459

Mashimo PA, Yamamoto Y, Slots J, et al. (1983) The periodontal microflora of juvenile diabetics: culture, immunofluorescence, and serum antibody studies. J Periodontol, 54, 420–430.

Cruz GA, de Toledo S, Sallum EA, et al. (2008) Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J. Periodontol., 79, 1150–1157.

Campus G, Salem A, Uzzau S, et al. (2005) Diabetes and Periodontal Disease: A Case‐Control Study -. J. Periodontol., 76, 418–425.

Ganesan,S.M., Joshi,V., Fellows,M., et al. (2017) A tale of two risks: Smoking, diabetes and the subgingival microbiome. ISME J., 11, 2075–2089. https://doi.org/10.1038/ismej.2017.73 http://www.ncbi.nlm.nih.gov/pubmed/28534880

Graves,D.T., Corrêa,J.D. and Silva,T.A. (2019) The Oral Microbiota Is Modified by Systemic Diseases. J. Dent. Res., 98, 148–156. https://doi.org/10.1177/0022034518805739 http://www.ncbi.nlm.nih.gov/pubmed/30359170

Polak,D. and Shapira,L. (2018) An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J. Clin. Periodontol., 45, 150–166. https://doi.org/10.1111/jcpe.12803 http://www.ncbi.nlm.nih.gov/pubmed/29280184

Ozturk A, Bilgici B, Odyakmaz S,K.E. (2012) The relationship of periodontal disease severity to serum and GCF substance P levels in diabetics. Quintessence Int, 43, 587–597. http://www.ncbi.nlm.nih.gov/pubmed/22670254

Shaker,O., Ghallab,N.A., Hamdy,E. et al. (2013) Inducible nitric oxide synthase (iNOS) in gingival tissues of chronic periodontitis with and without diabetes: Immunohistochemistry and RT-PCR study. Arch. Oral Biol., 58, 1397–1406. https://doi.org/10.1016/j.archoralbio.2013.05.003 http://www.ncbi.nlm.nih.gov/pubmed/23830615

Gokhale,N.H., Acharya,A.B., Patil,V.S., et al. (2014) Resistin Levels in Gingival Crevicular Fluid of Patients With Chronic Periodontitis and Type 2 Diabetes Mellitus. J. Periodontol., 85, 610–617. https://doi.org/10.1902/jop.2013.130092 http://www.ncbi.nlm.nih.gov/pubmed/23805816

Jiang,S.Y., Wei,C.C., Shang,T.T., et al. (2012) High glucose induces inflammatory cytokine through protein kinase C-induced toll-like receptor 2 pathway in gingival fibroblasts. Biochem. Biophys. Res. Commun., 427, 666–670. https://doi.org/10.1016/j.bbrc.2012.09.118 http://www.ncbi.nlm.nih.gov/pubmed/23026048

Journal of Periodontology - 2014 - Yang - Toll‐Like Receptor 4 Mediated Hyper‐Responsiveness of Gingival Epithelial Cells.pdf.

Chang, P. C., Tsai, S. C., Chong, et al. (2014) Phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)- AGE receptor axis to modulate experimental peri- odontitis in rats. J. Periodontol., 85, e268–e276.

Lalla,E., Lamster,I.B., Feit,M., et al. (2000) Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J. Clin. Invest., 105, 1117–1124. https://doi.org/10.1172/JCI8942 http://www.ncbi.nlm.nih.gov/pubmed/10772656

Pietropaoli,D., Monaco,A., Del Pinto,R., et al. (2012) Advanced glycation end products: Possible link between metabolic syndrome and periodontal diseases. Int. J. Immunopathol. Pharmacol., 25, 9–17. https://doi.org/10.1177/039463201202500102 http://www.ncbi.nlm.nih.gov/pubmed/22507312

Bullon,P., Morillo,J.M., Ramirez-Tortosa,M.C., et al. (2009) Metabolic syndrome and periodontitis: Is oxidative stress a common link? J. Dent. Res., 88, 503–518. https://doi.org/10.1177/0022034509337479 http://www.ncbi.nlm.nih.gov/pubmed/19587154

Soboku,K., Kikuchi,T., Fujita,S., et al. (2014) Altered Gene Expression in Gingival Tissues and Enhanced Bone Loss in Rats With Diabetes With Experimental Periodontitis. J. Periodontol., 85, 455–464. https://doi.org/10.1902/jop.2013.120705 http://www.ncbi.nlm.nih.gov/pubmed/23730973

Saxena,S., Venugopal,R., Chandrayan Rao,R., Yuwanati,M.B., et al. (2020) Association of chronic periodontitis and type 2 diabetes mellitus with salivary Del-1 and IL-17 levels. J. Oral Biol. Craniofacial Res., 10, 529–534. https://doi.org/10.1016/j.jobcr.2020.08.013

Grdović,N., Rajić,J., Petrović,S.M., et al. (2016) Association of CXCL12 gene promoter methylation with periodontitis in patients with diabetes mellitus type 2. Arch. Oral Biol., 72, 124–133. https://doi.org/10.1016/j.archoralbio.2016.08.025 http://www.ncbi.nlm.nih.gov/pubmed/27580404

Luong,A., Tawfik,A.N., Islamoglu,H., et al. (2021) Periodontitis and diabetes mellitus co-morbidity: A molecular dialogue. J. Oral Biosci., 63, 360–369. https://doi.org/10.1016/j.job.2021.10.006 http://www.ncbi.nlm.nih.gov/pubmed/34728373

Sayfalar

117-126

Gelecek

13 Haziran 2022

Lisans

Lisans